BioLineRx begins phase 2 trial for pancreatic cancer treatment By Investing.com
© Reuters. TEL AVIV - BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical firm, has initiated the Part 2 CheMo4METPANC ...
© Reuters. TEL AVIV - BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical firm, has initiated the Part 2 CheMo4METPANC ...
Copyright © 2023 Money Wise Inc.
Money Wise Inc is not responsible for the content of external sites.